According to market research and competitive intelligence firm Fact.MR, the global ultrasound probe disinfection market is expected to grow from its estimated $551 million in 2023 to $1.24 billion by the end of 2033.
The process of eliminating germs, especially harmful ones, by heat or chemical means is known as disinfection.
According to the American Institute of Ultrasound in Medicine (AIUM), "infection control is a crucial aspect for safe and successful use of ultrasound in medicine."
By providing rapid access to clinical data, contemporary diagnostic ultrasonic imaging techniques have enhanced diagnosis. The ability of instant diagnostic data to take the place of more costly diagnostic testing has subsequently helped to reduce total healthcare costs.
Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8237
Given the variety of ultrasound imaging treatments available, the market for ultrasound probe disinfection has a lot of potential for growth. The aging of the global population is a major factor in the rise in the number of ultrasonography procedures. As more people age (65 and older) and become susceptible to hospital-acquired infections and chronic illnesses like cardiovascular diseases (CVDs) and other cancers, the need for disease detection and treatment is expected to increase steadily. As a result, these factors are increasing the sales of goods that disinfect ultrasound probes.
What Should Manufacturers Focus On for Ultrasound Probe Disinfection Systems?
Endocavitary and TEE probes are expensive, making automated reprocessors unaffordable for many hospitals in developing countries. With UV-C disinfectors and automated reprocessors costing thousands of dollars, healthcare facilities in these regions often prefer cheaper alternatives, like probe covers. The lack of strict disinfection regulations and limited awareness about infection risks further hinder proper disinfection practices in low-income nations.
Country-wise Analysis:
The demand for ultrasound probe disinfection technologies in the U.S. is expected to grow, driven by advancements in disinfection methods and increasing prevalence of hospital-acquired infections (HAIs). The rising use of sophisticated ultrasound probe disinfectors reflects this trend.
For example, the Center for Infectious Disease Research and Policy reported a 47% rise in hospital-acquired infections in 2020, prompting the adoption of high-level disinfection systems. Data from the Massachusetts Health & Hospital Association in May 2022 estimated that HAIs caused 1.7 million infections in U.S. hospitals.
Additionally, U.S. federal investment in biotechnology R&D reached approximately $7.77 billion in 2020, with funding for research centers increasing by 5.9% in 2020, further boosting the development and implementation of advanced disinfection technologies.
Competitive Landscape
Key players in the ultrasound probe disinfection market are capitalizing on the growing demand for ultrasound devices across various sectors. They are employing a combination of organic and inorganic strategies to boost their market share and strengthen their position.
In February 2019, Germitec launched a revolutionary chemical-free, rapid high-level disinfection (HLD) system for ultrasound probes. The Hypernova Chronos system uses UV-based HLD technology, designed for vaginal, external, and rectal ultrasound probes. This powerful disinfection method is effective against the human papillomavirus (HPV), both in vitro and ex vivo.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
Comments
0 comment